# IMHA in Dogs: Survival Rate and Life Expectancy Most dogs with immune-mediated hemolytic anemia (IMHA) who receive treatment survive the first few weeks, and many live for months to years afterward. The IMHA in dogs survival rate depends heavily on how sick the dog is at diagnosis, whether a trigger can be found, and how quickly treatment starts. Without treatment, this disease is usually fatal. This article is educational and is not a substitute for veterinary diagnosis or treatment. ## Quick Answer - With aggressive treatment, roughly 7 to 8 out of 10 dogs survive to go home from the hospital, and about 55% are still alive at 6 months [1]. - Long-term survival is possible. In one follow-up group, median survival reached about 4.6 years after stem cell therapy for dogs that had not responded to steroids [2]. - The most dangerous period is the first days to weeks, when anemia, blood clots, and organ damage cause most deaths [3]. - Dogs with a concurrent Babesia gibsoni infection have a worse prognosis than dogs with primary IMHA [4]. - Without treatment, IMHA is generally fatal, so any dog with sudden weakness, pale gums, or dark urine needs emergency care right away. ## What Is IMHA in Dogs? IMHA is a disease where a dog's own immune system attacks its red blood cells. Red blood cells carry oxygen. When they are destroyed faster than the body can replace them, the dog becomes anemic. The destruction can happen inside blood vessels (intravascular) or in the spleen and liver (extravascular). Either way, the result is the same: too few red blood cells, and a body that is starved for oxygen. IMHA is the leading cause of hemolytic anemia in dogs [5]. Hemolytic means the anemia comes from red blood cell destruction, not from blood loss or poor red blood cell production. ## Signs Owners Notice IMHA often comes on fast. You may notice: - Pale or white gums, sometimes with a yellow tint - Weakness, collapse, or trouble standing - Fast breathing or panting at rest - Dark yellow, orange, or brown urine - Vomiting, diarrhea, or not eating - A swollen belly from an enlarged spleen or liver - Fever or unexplained bruising Some dogs show mild signs for a few days before crashing. Others go from normal to critical in hours. Sudden collapse or white gums is an emergency. ## Causes and Risk Factors In many dogs, no trigger is ever found. This is called primary or non-associative IMHA. In other dogs, IMHA is secondary to something else. In a large screening study, 33% of dogs with IMHA had an associated condition [6]. Those included toxic exposures (11%), infections (8%), cancer (7%), and non-infectious inflammatory disease (6%) [6]. Older dogs were more likely to have an associated cause [6]. Tick-borne infections matter. Dogs with IMHA and a concurrent Babesia gibsoni infection had worse survival than dogs with primary IMHA [4]. This is one reason your veterinarian may run infection testing even when the anemia looks typical. Breed and age can play a role. Some breeds, including Cocker Spaniels, Poodles, and certain terriers, are overrepresented in IMHA cases. If you own a breed with known health risks, a breed-specific guide can help you understand the full picture, such as this [Bernese Mountain Dog Health Guide: Genetic Risks, Joint Care & Lifespan](/knowledge/veterinary-medicine/breed-specific-health/bernese-mountain-dog-health-guide-genetic-risks-joint-care-lifespan). ## How IMHA Is Diagnosed Your veterinarian will start with a physical exam and blood work. Key tests include: - Complete blood count to measure anemia and check for red blood cell changes - Reticulocyte count to see if the bone marrow is responding - Blood smear to look for red blood cell clumping or parasites - Chemistry panel to check liver, kidney, and bilirubin levels - Urinalysis, including bilirubin and protein measurement - Coagulation testing, because clotting problems are common - Infectious disease testing, especially for tick-borne organisms - Imaging to look for tumors, stones, or other triggers Urine testing can add useful information. In one study, urinary bilirubin was increased in IMHA patients, and the urine protein-to-creatinine ratio was elevated compared to controls [5]. The protein ratio also correlated with how severe the anemia was [5]. Your veterinarian may also calculate ratios from the blood count. These ratios help describe how inflamed the dog is and how the disease is behaving. ## Treatment Options Treatment usually starts in the hospital and continues at home for months. ### Immunosuppressive Therapy Steroids are the first-line treatment. Prednisolone is commonly used, and dexamethasone is another option. In one treatment protocol, dogs received prednisolone at 1 mg/kg every 12 hours by mouth, or dexamethasone sodium phosphate at 0.2 mg/kg every 24 hours intravenously [4]. Your veterinarian will calculate the exact dose based on your dog's weight and condition. Other immunosuppressive drugs may be added if steroids alone are not enough. About 15% to 30% of dogs fail to respond to steroid-based therapy [2]. These dogs need other options and have a narrow treatment window [2]. ### Supportive Care - Blood transfusions when anemia is severe - Intravenous fluids to support circulation and kidney function - Anti-clotting medication, because thromboembolism is a major cause of death [3] - Oxygen therapy for dogs struggling to breathe - Potassium supplementation if levels are low, since 39% of dogs with IMHA were hypokalemic at presentation in one study [7] ### Newer Options Intravenous allogeneic mesenchymal stem cell therapy has been studied in dogs with steroid-refractory IMHA. In a follow-up study of 137 dogs, median survival was 1,695 days (about 4.6 years) in the primary group, and estimated 1-year survival was 56.9% [2]. Survival probability stabilized at about 52% through 8.1 years of follow-up [2]. This is not a standard first-line treatment, but it is an area of active research. If your dog is hospitalized and critically ill, it helps to understand how veterinarians judge recovery in other severe conditions. This overview of [Sepsis in Dogs: Prognostic Indicators and Survival Rates](/knowledge/veterinary-medicine/emergency-critical-care/sepsis-dogs-prognostic-indicators-survival-rates) explains similar thinking about prognosis and survival. ## IMHA in Dogs Prognosis: What Survival Looks Like This is the section most owners want. The numbers below come from real studies, but they describe groups of dogs, not your dog. | Time Point | Survival Rate | Source | |---|---|---| | Discharge from hospital | 80% | | | 1 month after diagnosis | 70% | | | 6 months after diagnosis | 55% | | | 1 year (steroid-refractory dogs after stem cell therapy) | 56.9% | | | Median survival (steroid-refractory dogs after stem cell therapy) | 1,695 days (4.6 years) | | Several factors push a dog toward the lower end of these ranges: - A concurrent Babesia gibsoni infection [4] - Severe anemia at presentation - Kidney injury, shown by high urine protein or bilirubin levels [5] - Blood clotting problems, which are common and often fatal [3] - Failure to respond to steroids within the first days of treatment [2] Dogs that survive the first month tend to do much better long term. Many go into remission and can eventually taper off medication. ## IMHA in Dogs Life Expectancy With Treatment With treatment, life expectancy varies from weeks to many years. Some dogs die in the first days despite aggressive care. Others live normal lifespans after remission. In the stem cell follow-up study, median survival was 4.6 years in the primary group, and survival held steady at about 52% through more than 8 years [2]. That group included dogs that had already failed standard steroid treatment, so it represents a harder-to-treat population. Dogs that respond well to first-line steroids may do better. Relapse is possible. Your veterinarian will monitor blood counts regularly, especially during the first months and during any medication changes. ## IMHA in Dogs Life Expectancy Without Treatment Without treatment, IMHA is generally fatal. The immune system keeps destroying red blood cells, and the body cannot keep up. Most untreated dogs die within days to a few weeks from severe anemia, organ failure, or blood clots. There is no safe watch-and-wait approach for this disease. If your dog has signs of IMHA, treatment needs to start right away. ## Recovery and Long-Term Management Recovery is a marathon, not a sprint. - Expect frequent blood tests, often weekly at first, then less often. - Steroid doses are usually tapered slowly over weeks to months. Do not stop them suddenly. - Watch for side effects like increased thirst, urination, appetite, and panting. These are common on steroids. - Keep follow-up appointments even when your dog looks normal. - Ask your veterinarian about clot prevention, because thrombosis risk can persist [3]. - Track your dog's energy, appetite, and gum color at home. Some dogs need lifelong low-dose medication. Others achieve remission and need no treatment. Your dog's individual course will guide the plan. ## Prevention You cannot always prevent IMHA, but you can lower some risks. - Use tick prevention year-round, since tick-borne infections can trigger or worsen IMHA [4]. - Avoid known toxins and keep medications, human drugs, and certain foods out of reach [6]. - See your veterinarian promptly for any illness, especially infections or inflammatory conditions [6]. - Keep routine wellness visits so problems are caught early. - If your dog has a breed predisposition, talk with your veterinarian about what to watch for. Understanding normal aging and lifespan can also help you set realistic expectations for your dog. This guide on [How Long Do Dogs Live For](/knowledge/veterinary-medicine/clinical-methods/how-long-do-dogs-live) covers typical lifespans by size and breed. ## Limitations and When to Contact a Veterinarian No article can tell you what will happen to your specific dog. IMHA is unpredictable, and individual cases need a veterinarian who can examine your dog, review lab results, and adjust treatment. Call your veterinarian the same day if you notice: - Pale gums that are not improving - Mild weakness or a single episode of collapse - Dark urine for the first time - Vomiting or diarrhea that lasts more than a day - Your dog refuses food for more than 24 hours Go to an emergency clinic now if you see: - White or blue gums - Collapse that does not resolve in seconds - Struggling to breathe or breathing with the belly - Seizures or extreme confusion - Bleeding that will not stop Keep routine recheck visits even when your dog seems fine. Blood work can catch a relapse before your dog looks sick. ## Frequently Asked Questions ### Can a dog fully recover from IMHA? Yes, many dogs achieve remission and live normal lives. Recovery means the immune attack stops, red blood cell counts return to normal, and medication can be tapered. Some dogs need long-term low-dose treatment to stay in remission. ### How long can a dog live after an IMHA diagnosis? It depends on how the dog responds to treatment and whether there are complicating factors. Some dogs live only weeks, while others live for years after diagnosis. Dogs that survive the first month have a much better long-term outlook. ### Is IMHA painful for dogs? The anemia itself causes weakness and lethargy more than pain. However, blood clots, organ swelling, and transfusions can cause discomfort. Your veterinarian can manage pain and anxiety during treatment. ### Can IMHA come back after treatment? Yes, relapse is possible, especially if medication is stopped too quickly or if a new trigger appears. This is why veterinarians taper steroids slowly and monitor blood counts regularly. Report any return of symptoms right away. ### Should I euthanize my dog with IMHA? That is a deeply personal decision and one to make with your veterinarian. Many dogs survive with treatment, so it is worth discussing prognosis, cost, and quality of life before deciding. If your dog is suffering and treatment is not working, humane euthanasia may be the kindest choice. ## Related Articles - [Sepsis in Dogs: Prognostic Indicators and Survival Rates](/knowledge/veterinary-medicine/emergency-critical-care/sepsis-dogs-prognostic-indicators-survival-rates) - [ivdd in dogs](/knowledge/veterinary-medicine/clinical-methods/ivdd-in-dogs) - [Bernese Mountain Dog Health Guide: Genetic Risks, Joint Care & Lifespan](/knowledge/veterinary-medicine/breed-specific-health/bernese-mountain-dog-health-guide-genetic-risks-joint-care-lifespan) - [How Long Do Dogs Live For](/knowledge/veterinary-medicine/clinical-methods/how-long-do-dogs-live) - [Bernese Mountain Dog Care, Health, Temperament, Size and Lifespan](/knowledge/veterinary-medicine/preventive-care/bernese-mountain-dog-care-health-lifespan) - [How Long Do Dogs Live](/knowledge/veterinary-medicine/clinical-methods/how-long-do-dogs-live) - [IMHA in Dogs and Cats: Immune-Mediated Anemia Explained](/knowledge/veterinary-medicine/senior-and-chronic-care/imha-dogs-cats-explained) - [Jaundice in Dogs: Survival Rate and Recovery Time](/knowledge/veterinary-medicine/senior-and-chronic-care/jaundice-dogs-survival-recovery) ## References 1. [Retrospective Evaluation of Hematological Ratios in Dogs With Nonassociative Immune-Mediated Hemolytic Anemia: 206 Cases](https://pubmed.ncbi.nlm.nih.gov/40231788/). Journal of veterinary internal medicine, 2025. 2. [Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study](https://pubmed.ncbi.nlm.nih.gov/42466752/). Stem cells and development, 2026. 3. [Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia](https://pubmed.ncbi.nlm.nih.gov/40538729/). Frontiers in veterinary science, 2025. 4. [Concurrent Babesia gibsoni infection as a negative prognostics indicator of survival in dogs diagnosed with immune-mediated hemolytic anemia: A prospective cohort study](https://pubmed.ncbi.nlm.nih.gov/42448039/). Topics in companion animal medicine, 2026. 5. [Assessment of Renal Function and Bilirubin Measurement in Urine as Prognostic Value in Immune-Mediated Hemolytic Anemia in Dogs](https://pubmed.ncbi.nlm.nih.gov/42018897/). Anais da Academia Brasileira de Ciencias, 2026. 6. [Multicenter, Retrospective Determination of the Clinical Utility of Screening Tests in Dogs With Immune-Mediated Hemolytic Anemia in the United Kingdom and Ireland](https://pubmed.ncbi.nlm.nih.gov/40944960/). Journal of veterinary internal medicine, 2025. 7. [Semiquantitative acid-base analysis in hypokalemic dogs with immune-mediated hemolytic anemia](https://pubmed.ncbi.nlm.nih.gov/40458759/). Frontiers in veterinary science, 2025. ## Further Reading - [Merck Veterinary Manual: Dog Owners](https://www.merckvetmanual.com/dog-owners) - [Cornell Richard P. Riney Canine Health Center: Canine Health Information](https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information) - [American Veterinary Medical Association: Pet Care](https://www.avma.org/resources-tools/pet-owners/petcare)